{"title":"口服避孕药配方和卵巢囊肿:FDA委员会发现低剂量单相或三相制剂不会增加卵泡增大的风险。","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":84492,"journal":{"name":"Contraception Report","volume":"5 1","pages":"6-9"},"PeriodicalIF":0.0000,"publicationDate":"1994-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":84492,\"journal\":{\"name\":\"Contraception Report\",\"volume\":\"5 1\",\"pages\":\"6-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1994-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Contraception Report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contraception Report","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.